CJC-1295 research guide for Hérépian. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
For anyone in Hérépian trying to locate CJC-1295, the foundational reality is that this compound is available only through an online research supply market. What this means for Hérépian researchers is that physical proximity is irrelevant compared to your ability to assess COA data — and those quality checks are accessible to anyone. A legitimate CJC-1295 supplier's COA needs to show HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all traceable to your specific batch. Use this guide to evaluate CJC-1295 vendors rigorously — the standards covered in this guide work regardless of your location.
CJC-1295 Mechanisms Explained
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Hérépian researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Where to Buy CJC-1295 — A Researcher's Guide
The first step for any Hérépian researcher sourcing CJC-1295 is identifying 2-3 vendors with documented positive community reputations — organic rankings are no guide to actual CJC-1295 quality. Mass spectrometry in the COA confirms that the main HPLC peak is actually CJC-1295 and not a structurally similar impurity — HPLC purity alone does not confirm what the compound actually is. Positive vendor signals beyond COA quality: multi-year operating history, customer service that can discuss analytical methods, and temperature-appropriate packaging with desiccant. For Hérépian researchers making a first CJC-1295 purchase: verify the vendor against this framework, order conservatively at first, and verify batch traceability on arrival before use.
Order CJC-1295 — ships to Hérépian
COA-verified · International tracking · Research grade
All use of CJC-1295 in Hérépian or anywhere constitutes research use — this compound is not approved for therapeutic human application, and all handling should follow research laboratory protocols. Reconstitute CJC-1295 with bacteriostatic water at a concentration matched to your dosing requirements; a standard 5mg in 2mL gives a 2.5mg/mL solution — or 25mcg per insulin syringe unit. Verify the endotoxin level in your CJC-1295 batch COA before use in any in-vivo protocol — look for results stated as EU/mg and compare against acceptable research limits for your application. For any individual considering CJC-1295 outside a formal research context: seek medical advice first — this compound is not approved for human use and its safety characterisation does not match that of regulated drugs.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
